Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM

K-Number: K043245 · 2005-04-29

ApplicantEps Bio Technology Corp.
Decision Date2005-04-29
Product CodeCGA
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Eps Bio Technology Corp.. It received FDA 510(k) clearance on 2005-04-29 under 510(k) number K043245. The device is classified under product code CGA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM?

EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM is a medical device that received FDA 510(k) clearance on 2005-04-29. The listed applicant is Eps Bio Technology Corp.. The 510(k) number is K043245.

When did EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM receive FDA 510(k) clearance?

EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM received FDA 510(k) clearance on 2005-04-29, under 510(k) number K043245.

Who is the listed applicant for EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM?

The FDA 510(k) record lists Eps Bio Technology Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM?

The FDA product code for EPS EASY PAIN SUPREME SELF MONITORING BLOOD GLUCOSE SYSTEM is CGA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Eps Bio Technology Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K201258EASYMAX Tag Self-Monitoring Blood Glucose SystemK190189MDT2 BLE Self-Monitoring Blood Glucose SystemK182057EasyMax BT Self-Monitoring Blood Glucose SystemK121207EASYMAX MU SELF MONITORING BLOOD GLUCOSE SYSTEM, EASYMAX MU PRO SELF MONITORING BLOOD GLUCOSE SYSTEMK113243EM50 SELF MONITORING BLOOD GLUCOSE SYSTEMK112901EME SELF MONITORING BLOOD GLUCOSE SYSTEM, EME PRO SELF MONITORING BLOOD GLUCOSE SYSTEM

View all 21 devices →

Related Devices (Code: CGA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252488ABL90 FLEX PLUS SystemRadiometer Medicals ApsK210933YSI 2900C Biochemistry AnalyzerYsi, Inc.K220328EasyStat 300Medica CorporationK223179Cholestech LDX ™ SystemAlere San Diego, Inc.K223755i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.K223710i-STAT CG8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑